Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CKD-350 [Phase 3]

View source ↗

Summary

The document reports an ongoing Phase 3 trial evaluating CKD-350 for dry eye syndrome, with no current status disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• CKD-350

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dry Eye Syndrome | Phase 3 | Status: UNKNOWN